Abstract:Cardiovascular diseases plague human health because of the lack of transplantable small-diameter blood vessel (SDBV) grafts. Although expanded polytetrafluoroethylene (ePTFE) has the potential to be used as a biocompatible material for SDBV grafts, long-term patency is still the biggest challenge. As discussed in this paper, by virtue of a novel material formulation and a new and benign alcohol/water lubricating agent, biofunctionalized ePTFE blood vessel grafts aimed at providing long-term patency were fabricated. Compared to the most prevalent modification of PTFE, namely surface treatment, this method realized bulk treatment, which could guarantee homogeneous and long-lasting performance throughout PTFE products. These blood vessel grafts included embedded functional biomolecules, such as arginylglycylaspartic acid, heparin, and selenocystamine, using water as a solvent in paste extrusion and in the expansion of ePTFE. Fourier-transform infrared spectroscopy, X-ray photoelectron spectroscopy, and scanning electron microscope results confirmed the existence of these targeting biomolecules in the as-fabricated ePTFE blood vessel grafts. Meanwhile, the greatly improved biological functions of the grafts were demonstrated <i>via</i> live and dead assays, cell morphology, CD31 staining, nitric oxide (NO) release, and anticoagulation tests. This novel and benign material formulation and fabrication method provides an opportunity to produce multibiofunctional ePTFE blood vessel grafts in a single step, thus yielding a potent product with significant commercial and clinical potential.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.biomac.0c00897?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.biomac.0c00897</a>.SEM of ePTFE fabricated by using naphtha as lubricants; SEM of ePTFE with different expanded ratios; XPS survey scans of ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA; fluorescence images of HCAECs cultured on different grafts for 4 h; fluorescence images of HCAECs cultured on ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA grafts for 10 days, respectively; immunochemical staining of HCAECs incubated on neat ePTFE and biofunctionalized ePTFE grafts; and element percentage results of ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA (<a class="ext-link" href="/doi/suppl/10.1021/acs.biomac.0c00897/suppl_file/bm0c00897_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A Quick and Effective Modification Method to Improve the Patency and Endothelialization of Cryopreserved Allogenic Blood Vessels

Functionalization of in Vivo Tissue-Engineered Living Biotubes Enhance Patency and Endothelization Without the Requirement of Systemic Anticoagulant Administration.

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

One-Pot Covalent Grafting of Gelatin on Poly(Vinyl Alcohol) Hydrogel to Enhance Endothelialization and Hemocompatibility for Synthetic Vascular Graft Applications.

Tetramethylpyrazine-derived Polyurethane for Improved Hemocompatibility and Rapid Endothelialization

Surface Modification of Polycarbonate Urethane by Grafting Polyethylene Glycol and Bivalirudin Drug for Improving Hemocompatibility

Decellularized Scaffold-Based Poly(ethylene Glycol) Biomimetic Vascular Patches Modified with Polyelectrolyte Multilayer of Heparin and Chitosan: Preparation and Vascular Tissue Engineering Applications in a Porcine Model.

Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization.

Dynamically Cross-Linked Double-Network Hydrogels with Matched Mechanical Properties and Ideal Biocompatibility for Artificial Blood Vessels

Biologically Functionalized Expanded Polytetrafluoroethylene Blood Vessel Grafts

Amelioration of Blood Compatibility and Endothelialization of Polycaprolactone Substrates by Surface-Initiated Atom Transfer Radical Polymerization

Biomimetic Niche of Vascular Intima with Biophysical Orientation and Biochemical Stimulation for Rapid Endothelialization and Long-Term Patency

Site-directed Immobilization of Antibodies Onto Blood Contacting Grafts for Enhanced Endothelial Cell Adhesion and Proliferation

Chitosan-Heparin Polyelectrolyte Multilayer-Modified Poly(vinyl alcohol) Vascular Patches based on a Decellularized Scaffold for Vascular Regeneration

Photo-induced universal modification of small-diameter decellularized blood vessels with a hemocompatible peptide improves in vivo patency

Prevention of Osmotic Injury to Human Umbilical Vein Endothelial Cells for Biopreservation: A First Step Toward Biobanking of Endothelial Cells for Vascular Tissue Engineering

Acellular Vascular Scaffolds Modified by Ammonium Phosphate Zwitterions Can Effectively Resist Thrombosis and Promote Endothelialization in Vitro

Abstract 2027: Enhancing Cell-based Therapies With Peptide-modified Thermoresponsive Citrate-based Biomaterials For Treatment Of Critical Limb Ischemia